Cite
HARVARD Citation
Keystone, E. et al. (2014). Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension. Annals of the rheumatic diseases. 73 (12), pp. 2094-2100. [Online].